HP
Hank Plain
OtherModeratePartner at Lightstone Ventures
8
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Hank Plain.
Investment Thesis & Strategy
Hank Plain, as a partner at Lightstone Ventures, invests in various stages of biotech, medical devices, and pharmaceutical companies, seeking innovative solutions with high growth potential.
Investment Activity
Deals per year over the last 11 years
1
20063
20070
20081
20091
20101
20110
20120
20130
20140
20151
2016Portfolio Companies
Selected investments from their portfolio of 8 companies
C
Cyteir Therapeutics
Biotech · Series A, 2016
E
Earlens
Healthcare · Series C+, 2011
C
Claret Medical
Healthcare · Series B, 2010
K
Kona Medical
Healthcare · Series B, 2009
S
SetPoint Medical
Biotech · Series C+, 2007
A
Ardian
Healthcare · Series C+, 2007
N
Nuvaira
Healthcare · Series C+, 2007
M
Miramar Labs
Healthcare · Series C+, 2006
Frequently Asked Questions
Hank Plain focuses on Seed stage investments.